Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo

International Journal of Cancer

Volumn 86, Issue 2, 2000, Pages 269-275

  Azemar, Marc ^a   Schmidt, Mathias ^a,f   Arlt, Friederike ^b   Kennel, Pierre ^c   Brandt, Burkhard ^d   Papadimitriou, Apollon ^a   Groner, Bernd ^e   Wels, Winfried ^e  

^a TUMOR BIOLOGY CENTER   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Hospices Civils Colmar   (France)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^f ASTA MEDICA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RECOMBINANT ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL VIABILITY; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ONCOGENE NEU; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL TOXINS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; EXOTOXINS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOTOXINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; VIRULENCE FACTORS;

EID: 0034087465     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000415)86:2<269::AID-IJC18>3.0.CO;2-8     Document Type: Article

References (20)

1. ALTENSCHMIDT, U., SCHMIDT, M., GRONER, B. and WELS, W., Targeted therapy of schwannoma cells in immunocompetent rats with an erbB2-specific antibody toxin. Int. J. Cancer, 73, 117-124 (1997).
2. DASSONVILLE, O., FORMENTO, J.L., FRANCOUAL, M., RAMAIOLI, A., SANTINI, J., SCHNEIDER, M., DEMARD, F. and MILANO, G., Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J. clin. Oncol., 11, 1873-1878 (1993).
3. FAN, Z. and MENDELSOHN, J., Therapeutic application of anti-growth factor receptor antibodies. Curr. Opin. Oncol., 10, 67-73 (1998).
4. GRANDIS, J.R., MELHEM, M.F., GOODING, W.E., DAY, R., HOLST, V.A., WAGENER, M.M., DRENNING, S.D. and TWEARDY, D.J., Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J. nat. Cancer Inst., 90, 824-832 (1998).
5. GRONER, B., WICK, B., JESCHKE, M., FIEBIG, H.H., DENGLER, W., RUNAU, T., MIHATSCH, M., KAHL, R., SCHMIDT, M., WELS, W. and STÖCKLIN, E., Intra-tumoral application of a heregulin-exotoxin-a fusion protein causes rapid tumor regression without adverse systemic or local effects. Int. J. Cancer, 70, 682-687 (1997).
6. HWANG, J., FITZGERALD, D.J., ADHYA, S. and PASTAN, I., Functional domains of Pseudomonasexotoxin identified by deletion analysis of the gene expressed in E. coli. Cell, 48, 129-136 (1987).
7. HYNES, N.E., GERBER, H.A., SAURER, S. and GRONER, B., Overexpression of the c-erbB-2 protein in human breast tumor cell lines. J. cell. Biochem., 39, 167-173 (1989).
8. IBRAHIM, S.O., VASSTRAND, E.N., LIAVAAG, P.G., JOHANNESSEN, A.C. and LILLEHAUG, J.R., Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck. Anticancer Res., 17, 4539-4546 (1997).
9. JANNOT, C.B., BEERLI, R.R., MASON, S., GULLICK, W.J. and HYNES, N.E., Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells. Oncogene, 13, 275-282 (1996).
10. PRESS, M.F., CORDON-CARDO, C. and SLAMON, D.J., Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene, 5, 953-962 (1990).
11. REAL, F.X., RETTIG, W.J., CHESA, P.G., MELAMED, M.R., OLD, L.J. and MENDELSOHN, J., Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res., 46, 4726-4731 (1986).
12. REITER, Y. and PASTAN, I., Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis. Trends Biotechnol., 16, 513-520 (1998).
13. RIVIERE, A., BECKER, J. and LONING, T., Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer. Cancer, 67, 2142-2149 (1991).
14. SANTINI, J., FORMENTO, J.L., FRANCOUAL, M., MILANO, G., SCHNEIDER, M., DASSONVILLE, O. and DEMARD, F., Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck, 13, 132-139 (1991).
15. SCHMIDT, M., VAKALOPOULOU, E., SCHNEIDER, D.W. and WELS, W., Construction and functional characterization of scFv(14E1)-ETA - a novel, highly potent antibody toxin specific for the EGF receptor. Brit. J. Cancer, 75, 1575-1584 (1997).
16. WELS, W., BEERLI, R., HELLMANN, P., SCHMIDT, M., MARTE, B.M., KORNILOVA, E.S., HEKELE, A., MENDELSOHN, J., GRONER, B. and HYNES, N.E., EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins. Int. J. Cancer, 60, 137-144 (1995).
17. WELS, W., HARWERTH, I.M., MUELLER, M., GRONER, B. and HYNES, N.E., Selective inhibition of tumor cell growth by a recombinant single-chain antibody toxin specific for the erbB-2 receptor. Cancer Res., 52, 6310-6317 (1992).
18. WINGO, P.A., TONG, T. and BOLDEN, S., Cancer statistics, 1995. CA Cancer J. Clin., 45, 8-30 (1995).
19. XIA, W., LAU, Y.K., ZHANG, H.Z., LUI, A.R., LI, L., KIYOKAWA, N., CLAYMAN, G.L., KATZ, R.L. and HUNG, M.C., Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. Clin. Cancer Res., 3, 3-9 (1997).
20. YIN, X.Y., DONOVAN-PELUSO, M., WHITESIDE, T.L., JOHNSON, J.T., DAY, R., HERBERMAN, R.B. and LOCKER, J., Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck. Genes Chromosomes Cancer, 3, 443-454 (1991).